Inspired by the upcoming CNN Special Report, Pot Vs. Pills, expected to be aired on Sunday by Dr. Sanjay Gupta, a U.S. company will launch a new campaign promoting marijuana as an alternative to the opioid-based medications.
Cannabis Science, Inc. (OTC: CBIS) and its partner, Cali RX, said on Friday that they are launching a new campaign to lend its voice that marijuana is an alternative.
The campaign “Cannabis Science to End Opioids Deaths Now Campaign!” will address what it is currently described as the opioid crisis.
Marijuana advocates have long touted that the green herb is not only nature’s best alternative to ease the pain, but an alternative to the deadly and addictive opioid-based pills.
“We believe we need to take the opioid fight to the streets!” said Raymond C. Dabney, Cannabis Science’s President, CEO, and Co-founder.
Cannabis Science specializes in the development of cannabinoid-based medicines.
“We will be discussing the Company’s major initiatives, the newest ‘Cannabis Science to End Opioids Deaths Now Campaign!’ presented as another ‘iCannabinoid, We the People Campaign!” he added.
The campaign “will bring in special guests to discuss scholarship programs and special opportunities available through Cannabis Science’s educational partners, including American States University, American Heritage University School of Law, and the Raymond C. Dabney University.”
Dabney said, “this opioid fight just got serious!”
Opioid-based medications are deadly. For example, Fentanyl, a synthetic opioid, is usually 50 times more potent than heroin.
Fentanyl is linked with more than 20,000 overdose deaths in 2016, according to some counts.